Fluorescence of Hematoporphyrin-Derivative for Detection and Characterization of Tumors

  • A. E. Profio
  • M. J. Carvlin
  • J. Sarnaik
  • L. R. Wudl


Hematoporphyrin-Derivative (HpD) is well known for its tumor specificity and its photodynamic effect in photoradiation therapy. HpD is also fluorescent, and can be used to detect and localize tumors such as in fluorescence endoscopy. There is also the possibility that the differential accumulation of HpD may vary not only between benign and malignant states, but at various stages in the transformation of normal cells to malignancy, permitting the fluorescence of HpD to serve as an indicator of the transformation. The concentration of HpD in the tumor and in surrounding nonmalignant tissue is needed to plan the therapy because the absorbed dose in photoradiation therapy is proportional to the concentration of HpD, and the space irradiance or energy flux density of the light at the dose point. Fluorescence may serve as an indicator of HpD concentration if corrections are made for competing absorption.


Fluorescence Yield Barrier Filter Photodynamic Effect Hematoporphyrin Derivative Nonmalignant Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D.R. Doiron, Fluorescence bronchoscopy for the early localization of lung cancer, Ph.D. Dissertation, University of California, Santa Barbara (1982).Google Scholar
  2. 2.
    A.E. Profio and D.R. Doiron, Dosimetry considerations in phototherapy, Med. Phys. 8:190 (1981).CrossRefGoogle Scholar
  3. 3.
    T.J. Dougherty, Personal communication (1983).Google Scholar
  4. 4.
    D. Kessel and T.H. Chou, Tumor-localizing components of the porphyrin preparation Hematoporphyrin Derivative, Cancer Res. 43:1994 (1983).Google Scholar
  5. 5.
    D.R. Doiron, L.O. Svaasand, and A.E. Profio, Light dosimetry in tissue: Application to photoradiation therapy, in: “Porphyrin Photosensitization”, D. Kessel and T.J. Dougherty, eds., Plenum Press, New York (1983).Google Scholar
  6. 6.
    A.E. Profio, D.R. Doiron, and E.G. King, Laser fluorescence bronchoscope for localization of occult lung tumors, Med. Phys. 6:523 (1979).CrossRefGoogle Scholar
  7. 7.
    O.J. Balchum, D.R. Doiron, A.E. Profio, and G.C. Huth, Fluorescence bronchoscopy for localizing early bronchial cancer and carcinoma in situ, in: “Recent Results in Cancer Research”, Vol. 82, Springer-Verlag, Berlin (1982).Google Scholar
  8. 8.
    A.E. Profio, D.R. Doiron, O.J. Balchum, and G.C. Huth, Fluorescence bronchoscopy for localization of carcinoma in situ, Med. Phys. 10:35 (1983).CrossRefGoogle Scholar
  9. 9.
    R.C. Benson, G.M. Farrow, J.H. Kinsey, D.A. Cortese, H. Zincke, and D.C. Utz, Detection and localization of in situ carcinoma of the bladder with Hematoporphyrin Derivative, Mayo Clin. Proc. 57:548 (1982).Google Scholar
  10. 10.
    L.O. Svaasand, D.R. Doiron, and T.J. Dougherty, Temperature rise during photoradiation therapy of malignant tumors, Med. Phys. 10:10 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • A. E. Profio
    • 1
  • M. J. Carvlin
    • 1
  • J. Sarnaik
    • 1
  • L. R. Wudl
    • 1
  1. 1.University of CaliforniaSanta BarbaraUSA

Personalised recommendations